advertisement
Shiga Y 41
Showing records 1 to 25 | Display all abstracts from Shiga Y86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Omodaka K
Current Eye Research 2020; 45: 1302-1308
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Sato K
Experimental Eye Research 2020; 193: 107997
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Kiyota N
Acta Ophthalmologica 2020; 98: e747-e753
86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Mabuchi F
American Journal of Ophthalmology 2020; 215: 135-140
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Shiga Y
Acta Ophthalmologica 2020; 98: e747-e753
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Mochida S
Experimental Eye Research 2020; 193: 107997
86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Mabuchi N
American Journal of Ophthalmology 2020; 215: 135-140
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Fujioka S
Current Eye Research 2020; 45: 1302-1308
86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Sakurada Y
American Journal of Ophthalmology 2020; 215: 135-140
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Yasuda M
Acta Ophthalmologica 2020; 98: e747-e753
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
An G
Current Eye Research 2020; 45: 1302-1308
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Tomimoto D
Experimental Eye Research 2020; 193: 107997
86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Yoneyama S
American Journal of Ophthalmology 2020; 215: 135-140
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Aizawa N
Acta Ophthalmologica 2020; 98: e747-e753
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Konuma T
Experimental Eye Research 2020; 193: 107997
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Udagawa T
Current Eye Research 2020; 45: 1302-1308
86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Kashiwagi K
American Journal of Ophthalmology 2020; 215: 135-140
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Kiyota N
Experimental Eye Research 2020; 193: 107997
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Tsuda S
Current Eye Research 2020; 45: 1302-1308
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Omodaka K
Acta Ophthalmologica 2020; 98: e747-e753
86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Iijima H
American Journal of Ophthalmology 2020; 215: 135-140
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Tsuda S
Experimental Eye Research 2020; 193: 107997
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Shiga Y
Current Eye Research 2020; 45: 1302-1308
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Tsuda S
Acta Ophthalmologica 2020; 98: e747-e753
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Shiga Y
Experimental Eye Research 2020; 193: 107997
